Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers - Full Text View

Sponsors and Collaborators:	Smith & Nephew Medical Ltd Smith & Nephew, Inc.
Information provided by:	Smith & Nephew Medical Ltd
ClinicalTrials.gov Identifier:	NCT00521027

Purpose

The purpose of this study is to compare the VERSAJET™ device with conventional surgical procedures (performed with a scalpel) in the debridement (removal of unhealthy tissue) of lower limb ulcers.

It is hypothesised that the time taken to debride lower limb ulcers will be quicker with the VERSAJET™ device than with conventional surgical procedures.

Condition	Intervention	Phase
Diabetic Foot Varicose Ulcer Pressure Ulcer	Device: Versajet Hydrosurgery System Procedure: Conventional surgical debridement techniques	Phase IV

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:	A Prospective, Comparative, Single-Centre Clinical Evaluation to Investigate the Skin-to-Skin Time of the First Surgical Debridement of Lower Extremity Ulcers With VERSAJET™ Hydrosurgery System and Conventional Debridement Techniques.

Resource links provided by NLM:

MedlinePlus related topics: Diabetic Foot Foot Health Leg Injuries and Disorders Pressure Sores Surgery

U.S. FDA Resources

Further study details as provided by Smith & Nephew Medical Ltd:

Primary Outcome Measures:

Reduction in the average skin-to-skin time of the first surgical debridement with VERSAJET™, compared to conventional debridement techniques. [ Time Frame: During surgery ]

Secondary Outcome Measures:

Difference in the total average time of the debridement procedure, including preparation, skin-to-skin and recovery, according to the debridement technique. [ Time Frame: Entry into OR holding area to discharge from recovery room ]
Difference in outcomes of the procedure, according to the debridement technique in terms of; time to wound closure, number of subsequent debridements, number of serious adverse events [ Time Frame: 3 months post-op ]

Enrollment:	46
Study Start Date:	April 2006
Study Completion Date:	September 2006

Arms	Assigned Interventions
Treatment Debridement with Versajet Hydrosurgery system	Device: Versajet Hydrosurgery System Debridement with Versajet Hydrosurgery System
Control Conventional surgical debridement techniques	Procedure: Conventional surgical debridement techniques Conventional surgical debridement with scalpel and pulse lavage

Detailed Description:

This is prospective, comparative clinical evaluation to investigate whether there is a reduction in the skin-to-skin time of the first surgical debridement with VERSAJET™, compared to conventional debridement techniques. Skin-to-skin time is defined as the time of incision to the end time of debridement (wound ready for dressing application). Conventional debridement is defined as scalpel plus pulse lavage.

The purpose of this comparison is to demonstrate the resource savings which VERSAJET™ may provide in terms of operating room (OR) and personnel time, in addition to the potential to reduce the procedure, and possibly anaesthetic, time for the patient. It is envisaged that this information, combined with the costs associated with the procedure, will also provide valuable economic data to help justify the use of VERSAJET™ from a financial perspective and support the future commercial success of the device.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients who are at least 18 years of age.
Males and females (provided they are not pregnant or, if of reproductive age, are using contraception).
Patients with a venous stasis, diabetic foot or decubitus reference ulcer located between the tibia and foot.
Patients undergoing surgical debridement of their reference ulcer in the operating room (OR).
Patients undergoing their first surgical debridement of the reference ulcer.
Patients suitable for debridement of their reference ulcer with both VERSAJET™ and conventional debridement techniques.
Patients who are able to understand the evaluation and are willing and able to provide written consent to participate in the evaluation.

Exclusion Criteria:

Patients with clinical signs of infection in the reference ulcer (e.g. purulence and / or odour).
Patients with haemophilia
Patients who have been treated with topical steroids, systemic immunosuppressants (including corticosteroids), anticoagulants or cytotoxic chemotherapy in the last 30 days, or who are anticipated to require such medications during the course of the study.
Patients known to have Acquired Immunodeficiency Syndrome (AIDS) or known to be infected with Human Immunodeficiency Virus (HIV).
Patients who suffer from acute or chronic bacterial, viral or fungal skin diseases that would interfere with wound healing.
Patients with a known history of poor compliance with medical treatment.
Patients who have participated in this evaluation previously or are currently participating in another clinical study.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00521027

Locations

United States, New Jersey
Clara Maass Medical Center
Belleville, New Jersey, United States, 07109

Sponsors and Collaborators

Smith & Nephew Medical Ltd

Smith & Nephew, Inc.

Investigators

Principal Investigator:

Wayne J Caputo, DPM

Clara Maass Medical Center

More Information

No publications provided

Study ID Numbers:	CE025VJT
Study First Received:	August 23, 2007
Last Updated:	August 23, 2007
ClinicalTrials.gov Identifier:	NCT00521027 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Smith & Nephew Medical Ltd:

Debridement
hydrosurgery
Versajet
leg ulcer

Study placed in the following topic categories:

Foot Ulcer
Diabetic Neuropathies
Skin Diseases
Ulcer
Vascular Diseases
Diabetes Mellitus
Endocrine System Diseases
Diabetic Angiopathies

Varicose Ulcer
Varicose Veins
Endocrinopathy
Skin Ulcer
Pressure Ulcer
Diabetes Complications
Diabetic Foot
Leg Ulcer

Additional relevant MeSH terms:

Foot Ulcer
Diabetic Neuropathies
Skin Diseases
Ulcer
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Diabetic Angiopathies
Varicose Ulcer

Pathologic Processes
Varicose Veins
Cardiovascular Diseases
Skin Ulcer
Pressure Ulcer
Diabetes Complications
Diabetic Foot
Leg Ulcer

ClinicalTrials.gov processed this record on July 02, 2009